Skip to main content
SpringerLink
Log in

How Common is Statin Use in the Oldest Old?

  • Current Opinion
  • Published:
Drugs & Aging Aims and scope Submit manuscript

A Correction to this article was published on 03 October 2018

This article has been updated

Abstract

There is a lack of evidence surrounding the efficacy of statins in the oldest old (≥ 80 years of age). As such, there is controversy surrounding use of statins in this population. We sought to evaluate the prevalence of statin use in the oldest old worldwide to understand the scope of this issue. We searched PubMed and grey literature over the last 5 years. Studies had to report the prevalence of statin use in adults ≥ 80 years of age. The first author performed screening and extracted data. Our search produced 1870 hits; 14 articles were considered eligible. We found three studies of nursing home residents, eight studies of community-dwelling patients and three studies in the combined population (i.e., both community-dwelling patients and nursing home residents). The prevalence of statin use ranged from 17 to 39% in nursing home residents, 12 to 59% for community-dwelling patients and 18 to 45% in combined populations. Beyond age 80 years, the prevalence of statin use appeared to decrease with advancing age. Statin use was more common as secondary prevention compared with primary prevention. The prevalence of statin use in the oldest old has increased over recent decades. The increase in prevalence appears to be more pronounced in the oldest old compared with younger old, as reported by two studies. Statins are widely used in the oldest old despite the lack of evidence in this population. Given how common statin use is in the oldest old, clinical evidence surrounding their efficacy in this group is urgently needed to guide appropriate use and shared decision-making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

  • 03 October 2018

    In Section 4.3 “Factors Associated with Statin Use in the Oldest Old”.

References

  1. Naci H, Brugts JJ, Fleurence R, Tsoi B, Toor H, Ades A. Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials. Eur J Prev Cardiol. 2013;20(4):641–57. https://doi.org/10.1177/2047487313480435.

    Article  PubMed  Google Scholar 

  2. Afilalo J, Duque G, Steele R, Jukema JW, de Craen AJM, Eisenberg MJ. Statins for secondary prevention in elderly patients. J Am Coll Cardiol. 2008;51(1):37–45. https://doi.org/10.1016/j.jacc.2007.06.063.

    Article  CAS  PubMed  Google Scholar 

  3. Savarese G, Gotto AM, Paolillo S, et al. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. J Am Coll Cardiol. 2013;62(22):2090–9. https://doi.org/10.1016/j.jacc.2013.07.069.

    Article  CAS  PubMed  Google Scholar 

  4. Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US preventive services task force. JAMA. 2016;316(19):2008–24. https://doi.org/10.1001/jama.2015.15629.

    Article  PubMed  Google Scholar 

  5. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia. JAMA. 2014;312(11):1136. https://doi.org/10.1001/jama.2014.10924.

    Article  CAS  PubMed  Google Scholar 

  6. Petersen LK, Christensen K, Kragstrup J. Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing. 2010;39(6):674–80. https://doi.org/10.1093/ageing/afq129.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360(9346):1623–30. https://doi.org/10.1016/S0140-6736(02)11600-X.

    Article  CAS  PubMed  Google Scholar 

  8. Han BH, Sutin D, Williamson JD, et al. Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial. JAMA Intern Med. 2017;177(7):955–65. https://doi.org/10.1001/jamainternmed.2017.1442.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Huesch MD. Association of baseline statin use among older adults without clinical cardiovascular disease in the SPRINT trial. JAMA Intern Med. 2018. https://doi.org/10.1001/jamainternmed.2017.7844.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kjekshus J, Apetrei E, Barrios V, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med. 2007;357(22):2248–61. https://doi.org/10.1056/NEJMoa0706201.

    Article  CAS  PubMed  Google Scholar 

  11. Krumholz HM. Statins evidence: when answers also raise questions. BMJ. 2016;354:i4963. https://doi.org/10.1136/bmj.i4963.

    Article  PubMed  Google Scholar 

  12. Noaman S, Ibrahim JE, Grenfell R. Prescribing statins for cardiovascular disease prevention in the old: an absence of evidence and an absence of guidelines. Heart Lung Circ. 2014;23(7):619–24. https://doi.org/10.1016/j.hlc.2014.03.002.

    Article  PubMed  Google Scholar 

  13. Campitelli MA, Maxwell CJ, Giannakeas V, et al. The variation of statin use among nursing home residents and physicians: a cross-sectional analysis. J Am Geriatr Soc. 2017;65(9):2044–51. https://doi.org/10.1111/jgs.15013.

    Article  PubMed  Google Scholar 

  14. Gnjidic D, Wilson N, March L, Cumming RG, Cameron ID, Hilmer SN. Statin utilisation patterns in older Australians living in residential care: 1-year prevalence study. Intern Med J. 2015;45(1):106–9. https://doi.org/10.1111/imj.12633.

    Article  CAS  PubMed  Google Scholar 

  15. Chokshi NP, Messerli FH, Sutin D, Supariwala AA, Shah NR. Appropriateness of statins in patients aged ≥ 80 years and comparison to other age groups. Am J Cardiol. 2012;110(10):1477–81. https://doi.org/10.1016/j.amjcard.2012.06.058.

    Article  CAS  PubMed  Google Scholar 

  16. Johansen M. Statin use in very elderly individuals, 1999–2012. JAMA Intern Med. 2015;7(October):25–6. https://doi.org/10.1001/jamainternmed.2015.4302.Author.

    Article  Google Scholar 

  17. Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Drug use in persons with and without Alzheimer’s disease aged 90 years or more. Age Ageing. 2016;45(6):900–4. https://doi.org/10.1093/ageing/afw141.

    Article  PubMed  Google Scholar 

  18. Upmeier E, Korhonen MJ, Helin-Salmivaara A, Huupponen R. Statin use among older Finns stratified according to cardiovascular risk. Eur J Clin Pharmacol. 2013;69(2):261–7. https://doi.org/10.1007/s00228-012-1328-0.

    Article  CAS  PubMed  Google Scholar 

  19. Turner JP, Shakib S, Singhal N, et al. Statin use and pain in older people with cancer: a cross-sectional study. J Am Geriatr Soc. 2014;62(10):1900–5. https://doi.org/10.1111/jgs.13051.

    Article  PubMed  Google Scholar 

  20. Gulliford M, Ravindrarajah R, Hamada S, Jackson S, Charlton J. Inception and deprescribing of statins in people aged over 80 years: cohort study. Age Ageing. 2017;46(6):1001–5. https://doi.org/10.1093/ageing/afx100.

    Article  PubMed  Google Scholar 

  21. Jacobs JM, Cohen A, Ein-Mor E, Stessman J. Cholesterol, statins, and longevity from age 70 to 90 years. J Am Med Dir Assoc. 2013;14(12):883–8. https://doi.org/10.1016/j.jamda.2013.08.012.

    Article  PubMed  Google Scholar 

  22. Proulx J, Hunt J. Drug use among seniors on public drug programs in Canada, 2012. Healthc Q. 2015;18(1):11–3.

    Article  PubMed  Google Scholar 

  23. Wallach-Kildemoes H, Stovring H, Holme Hansen E, Howse K, Pétursson H. Statin prescribing according to gender, age and indication: what about the benefit-risk balance? J Eval Clin Pract. 2016;22(2):235–46. https://doi.org/10.1111/jep.12462.

    Article  PubMed  Google Scholar 

  24. Tija J, Cutrona S, Peterson D, Reed G, Andrade S, Mitchell S. Statin discontinuation among nursing home residents with advanced dementia. J Am Geriatr Soc. 2014;62(11):2095–101. https://doi.org/10.1037/a0015862.Trajectories.

    Article  Google Scholar 

  25. Chee WJ, Abdullahi H, Chan Y, Rattle A, Snedden S, Junckerstorff R. Retrospective evaluation of statin prescription in the elderly. Intern Med J. 2018. https://doi.org/10.1111/imj.13996.

    Article  PubMed  Google Scholar 

  26. Noaman S, Al-Mukhtar O, Abramovic S, et al. Changes in statin prescription patterns in patients admitted to an Australian geriatric subacute unit. Heart Lung Circ. 2018. https://doi.org/10.1016/j.hlc.2017.12.009.

    Article  PubMed  Google Scholar 

  27. Strandberg TE, Urtamo A, Kähärä J, Strandberg AY, Pitkälä KH, Kautiainen H. Statin treatment is associated with a neutral effect on health-related quality of life among community-dwelling octogenarian men. J Gerontol A Biol Sci Med Sci. 2018. https://doi.org/10.1093/gerona/gly073.

    Article  PubMed  Google Scholar 

  28. Todd A, Husband A, Andrew I, Pearson SA, Lindsey L, Holmes H. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care. 2017;7(2):113–21. https://doi.org/10.1136/bmjspcare-2015-000941.

    Article  PubMed  Google Scholar 

  29. Tibrewala A, Jivan A, Oetgen WJ, Stone NJ. A comparative analysis of current lipid treatment guidelines: nothing stands still. J Am Coll Cardiol. 2018;71(7):794–9. https://doi.org/10.1016/j.jacc.2017.12.025.

    Article  PubMed  Google Scholar 

  30. Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129(25 suppl 2):S1–45. https://doi.org/10.1161/01.cir.0000437738.63853.7a.

    Article  PubMed  Google Scholar 

  31. Redberg RF, Katz MH. Statins for primary prevention: the debate is intense, but the data are weak. JAMA. 2016;316(19):1979–81. https://doi.org/10.1001/jama.2016.15085.

    Article  PubMed  Google Scholar 

  32. Sanchis-Gomar F, Perez-Quilis C, Leischik R, Lucia A. Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med. 2016;4(13):256. https://doi.org/10.21037/atm.2016.06.33.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Korhonen MJ, Ilomäki J, Sluggett JK, et al. Selective prescribing of statins and the risk of mortality, hospitalizations, and falls in aged care services. J Clin Lipidol. 2018. https://doi.org/10.1016/j.jacl.2018.02.012.

    Article  PubMed  Google Scholar 

  34. Clegg A, Bates C, Young J, et al. Development and validation of an electronic frailty index using routine primary care electronic health record data. Age Ageing. 2016;45(3):353–60. https://doi.org/10.1093/ageing/afw039.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kaehr E, Visvanathan R, Malmstrom TK, Morley JE. Frailty in nursing homes: the FRAIL-NH scale. J Am Med Dir Assoc. 2015;16(2):87–9. https://doi.org/10.1016/j.jamda.2014.12.002.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Unit of General Practice, Department of Public Health, University of Southern Denmark, J.B. Winsløws Vej 9A, 5000, Odense C, Denmark

    Wade Thompson, Jesper Bo Nielsen, Peter Haastrup & Dorte Ejg Jarbøl

  2. Research Unit of Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark

    Anton Pottegård

Authors
  1. Wade Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anton Pottegård
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jesper Bo Nielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter Haastrup
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dorte Ejg Jarbøl
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

WT conceived the article, performed the search, interpreted data, drafted and revised the manuscript. AP, JBN, PH, and DEJ interpreted data, drafted the article, and provided critical revisions. All authors gave final approval for publication and are accountable for all aspects of the work.

Corresponding author

Correspondence to Wade Thompson.

Ethics declarations

Funding

No external funds were used in the preparation of this manuscript.

Conflict of interest

Wade Thompson, Anton Pottegård, Jesper Bo Nielsen, Peter Haastrup, and Dorte Ejg Jarbøl declare no potential conflicts of interest that might be relevant to the contents of this manuscript.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 312 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thompson, W., Pottegård, A., Nielsen, J.B. et al. How Common is Statin Use in the Oldest Old?. Drugs Aging 35, 679–686 (2018). https://doi.org/10.1007/s40266-018-0567-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-018-0567-x

Search

Navigation